HCA Healthcare (HCA) Stock Rating Reaffirmed by Credit Suisse Group

Credit Suisse Group reissued their outperform rating on shares of HCA Healthcare (NYSE:HCA) in a research note published on Tuesday, December 26th. They currently have a $25.00 target price on the stock.

HCA has been the topic of several other research reports. ValuEngine downgraded shares of HCA Healthcare from a buy rating to a hold rating in a research note on Thursday, September 7th. KeyCorp restated an overweight rating and issued a $90.00 price target (down from $95.00) on shares of HCA Healthcare in a report on Thursday, October 19th. Morgan Stanley cut shares of HCA Healthcare from an equal weight rating to an underweight rating and set a $85.00 target price for the company. in a research note on Wednesday, December 20th. Citigroup upgraded shares of HCA Healthcare from a neutral rating to a buy rating in a research note on Tuesday, December 12th. Finally, Cantor Fitzgerald restated a buy rating and set a $90.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 31st. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus price target of $87.80.

Shares of HCA Healthcare (NYSE HCA) opened at $86.97 on Tuesday. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46. The company has a market cap of $31,270.00, a P/E ratio of 12.37, a price-to-earnings-growth ratio of 1.17 and a beta of 0.55. HCA Healthcare has a twelve month low of $71.18 and a twelve month high of $91.03.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. HCA Healthcare’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.45 earnings per share. equities research analysts predict that HCA Healthcare will post 6.56 EPS for the current year.

In other HCA Healthcare news, SVP Victor L. Campbell sold 8,000 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $75.82, for a total transaction of $606,560.00. Following the sale, the senior vice president now directly owns 127,275 shares in the company, valued at $9,649,990.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction dated Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the sale, the insider now owns 12,476 shares in the company, valued at $973,128. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,700 shares of company stock worth $1,773,872. Corporate insiders own 2.90% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in HCA. Mitsubishi UFJ Trust & Banking Corp increased its stake in HCA Healthcare by 0.9% in the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 628,845 shares of the company’s stock valued at $54,835,000 after purchasing an additional 5,870 shares during the last quarter. Pacer Advisors Inc. increased its stake in HCA Healthcare by 8.4% in the second quarter. Pacer Advisors Inc. now owns 7,093 shares of the company’s stock valued at $619,000 after purchasing an additional 548 shares during the last quarter. OMERS ADMINISTRATION Corp purchased a new position in HCA Healthcare in the second quarter valued at approximately $2,337,000. Micawber Capital LLC increased its stake in HCA Healthcare by 6.7% in the second quarter. Micawber Capital LLC now owns 26,256 shares of the company’s stock valued at $2,290,000 after purchasing an additional 1,641 shares during the last quarter. Finally, Commerce Bank increased its stake in HCA Healthcare by 1.4% in the second quarter. Commerce Bank now owns 13,320 shares of the company’s stock valued at $1,161,000 after purchasing an additional 182 shares during the last quarter. Hedge funds and other institutional investors own 75.34% of the company’s stock.

TRADEMARK VIOLATION WARNING: “HCA Healthcare (HCA) Stock Rating Reaffirmed by Credit Suisse Group” was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://stocknewstimes.com/2018/01/12/hca-healthcare-hca-rating-reiterated-by-credit-suisse-group.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply